$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Biodegradable, implantable drug delivery device, and process for preparing and using the same 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/00
출원번호 US-0186152 (1980-09-11)
발명자 / 주소
  • Sidman Kenneth R. (Wayland MA)
출원인 / 주소
  • Arthur D. Little, Inc. (Cambridge MA 02)
인용정보 피인용 횟수 : 197  인용 특허 : 0

초록

An implantable drug delivery device comprising a matrix formed of a poly-a

대표청구항

An implant device for the controllable release of at least one substance into a living host into which it is implanted, comprising (a) a substance to be released within a living host; and (b) a matrix material prepared from a block copolymer of the formula [Figure] [Figure] where R1, R2, R3 and R4 a

이 특허를 인용한 특허 (197)

  1. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry ; Wang Nai Fang, 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents.
  2. Siegel, Steven; Winey, Karen, 9-OH-risperidone controlled release composition.
  3. Bonuttti, Peter M, Acoustic therapy device.
  4. Milstein Sam J. ; Barantsevitch Evgueni ; Leone-Bay Andrea ; Wang Nai Fang ; Sarubbi Donald J. ; Santiago Noemi B, Active agent transport systems.
  5. Milstein Sam J. ; Barantsevitch Evgueni ; Leone-Bay Andrea ; Wang Nai Fang ; Sarubbi Donald J. ; Santiago Noemi B, Active agent transport systems.
  6. Milstein Sam J. ; Leone-Bay Andrea ; Sarubbi Donald J. ; Leipold Harry, Active agent transport systems.
  7. Benjamin John D. (Malvern GB2) Mears Adrian L. (Cheltenham GB2) White John C. (Lincoln GB2), Active silicon implant devices.
  8. Steiner Solomon S. (Mt. Kisco NY), Anhydrous delivery systems for pharmacological agents.
  9. Richter, Jacob, Apparatus and method for treating body tissues with electricity or medicaments.
  10. Richter, Jacob, Apparatus and method for treating body tissues with electricity or medicaments.
  11. Gibson, Peter, Apparatus for delivery of pharmaceuticals to the cochlea.
  12. Gibson, Peter, Apparatus for delivery of pharmaceuticals to the cochlea.
  13. Gibson, Peter, Apparatus for delivery of pharmaceuticals to the cochlea.
  14. Nova Michael P. ; Lillig John E. ; Karunaratne Kanchana Sanjaya Gunesekera ; Ewing William ; Satoda Yozo ; Potash Hanan, Automated sorting system for matrices with memory.
  15. Schmer Gottfried (Seattle WA), Bio-artificial organ using microencapsulated enzymes.
  16. Desai, Shrojalkumar M.; Ratner, Buddy D., Biocompatible amino acid anhydride polymers.
  17. Feijen Jan (Oude Grensweg NLX), Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents.
  18. Drobnk Jaroslav (Prague CSX) Stepnkov Helena (Prague CSX), Biodegradable implant and a method for preparation thereof.
  19. Bichon Daniel (Gaillard FRX), Biodegradable polypeptide and its use for the gradual release of drugs.
  20. Bichon Daniel (Gaillard FRX) Lamy Bernard (Carouge CHX) Borloz William (Nyon CHX), Biodegradable synthesis polypeptide and its therapeutic use.
  21. Sidman Kenneth R. (Wayland MA), Biodegradable, implantable drug delivery depots, and method for preparing and using the same.
  22. Urry Dan W., Bioelastomeric drug delivery system.
  23. Eastenson, Kyle; Kurdyumov, Aleksey V.; DuMez, Darin; Wormuth, Klaus; Lockwood, Nathan A., Bioerodable poly(etheresteramides) and medical article uses.
  24. Schacht Etienne (Staden BEX) Crommen Jan (Ghent BEX), Bioerodable sustained release implants.
  25. Marx Gerard (New York NY), Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use.
  26. Benner, Jeffrey D.; Cohen, Steven M., Bioresorbable drug eluting intravitreal implant system and method.
  27. Benner, Jeffrey D.; Cohen, Steven M., Bioresorbable drug eluting intravitreal implant system and method.
  28. Kaplan, Edward J., Brachytherapy seed.
  29. Soula, Rémi; Pouliquen, Gauthier; Chan, You-Ping, Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications.
  30. Williams,Michael S.; DeSimone,Joseph M., Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses.
  31. Milstein Sam J., Carbon-substituted diketopiperazine delivery systems.
  32. Cardinal John R. (Old Lyme CT) Curatolo William J. (Old Lyme CT) Ebert Charles D. (Brewster NY), Chitosan compositions for controlled and prolonged release of macromolecules.
  33. Soula, Gérard; Bryson, Nathan, Colloidal suspension of nanoparticles based on an amphiphilic copolymer.
  34. Touraud,Franck; Bryson,Nathan, Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same.
  35. Bryson,Nathan; Soula,G챕rard, Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation.
  36. Porter Garry L. (Wichita KS), Composition and method for protecting a therapeutic drug.
  37. Hossainy,Syed F. A.; Sanders Millare,Debbie; Wu,Steven Z., Composition for coating an implantable prosthesis.
  38. Walker, Kenneth W.; Gegg, Jr., Colin V., Compositions and methods for producing bioactive fusion proteins.
  39. Leone-Bay Andrea (Ridgefield CT) Ho Koc-Kan (Mt. Kisco NY) Press Jeffery Bruce (Brewster NY), Compositions for oral delivery of active agents.
  40. Santiago Noemi B. ; Haas Susan ; Leone-Bay Andrea, Compositions for the delivery of antigens.
  41. Santiago Noemi B. ; Haas Susan ; Leone-Bay Andrea ; Milstein Sam J. ; Barantsevitch Evgueni, Compositions for the delivery of antigens.
  42. Andrea Leone-Bay ; Koc-Kan Ho ; Donald J. Sarubbi ; Sam J. Milstein, Compounds and compositions for delivering active agents.
  43. Andrea Leone-Bay ; Koc-Kan Ho ; Donald J. Sarubbi ; Sam J. Milstein ; Nai Fang Wang, Compounds and compositions for delivering active agents.
  44. Leone Bay,Andrea; Milstein,Sam J.; Sarubbi,Donald J.; Leipold,Harry, Compounds and compositions for delivering active agents.
  45. Leone-Bay Andrea (Ridgefield CT) Paton Duncan R. (Purdys NY) Ho Koc-Kan (Mt. Kisco NY) DeMorin Frenel (Spring Valley NY), Compounds and compositions for delivering active agents.
  46. Leone-Bay Andrea ; Gschneidner David ; Wang Eric ; Sarubbi Donald J., Compounds and compositions for delivering active agents.
  47. Leone-Bay Andrea ; Ho Koc-Kan ; Sarubbi Donald J. ; Leipold Harry R., Compounds and compositions for delivering active agents.
  48. Leone-Bay Andrea ; Ho Koc-Kan ; Sarubbi Donald J. ; Milstein Sam J., Compounds and compositions for delivering active agents.
  49. Leone-Bay Andrea ; Ho Koc-Kan ; Sarubbi Donald J. ; Milstein Sam J., Compounds and compositions for delivering active agents.
  50. Leone-Bay Andrea ; Ho Koc-Kan ; Sarubbi Donald J. ; Milstein Sam J., Compounds and compositions for delivering active agents.
  51. Leone-Bay Andrea ; Ho Koc-Kan ; Sarubbi Donald J. ; Milstein Sam J., Compounds and compositions for delivering active agents.
  52. Leone-Bay Andrea ; Paton Duncan R. ; Ho Koc-Kan ; DeMorin Frenel, Compounds and compositions for delivering active agents.
  53. Leone-Bay Andrea ; Paton Duncan R. ; Ho Koc-Kan ; DeMorin Frenel, Compounds and compositions for delivering active agents.
  54. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry, Compounds and compositions for delivering active agents.
  55. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry, Compounds and compositions for delivering active agents.
  56. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry, Compounds and compositions for delivering active agents.
  57. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry, Compounds and compositions for delivering active agents.
  58. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry, Compounds and compositions for delivering active agents.
  59. Leone-Bay Andrea ; Wang Eric ; Sarubbi Donald J. ; Leipold Harry R., Compounds and compositions for delivering active agents.
  60. Leone-Bay Andrea ; Wang Eric Yanjun ; Sarubbi Donald J. ; Leipold Harry ; Wang Nai Fang, Compounds and compositions for delivering active agents.
  61. Sarubbi, Donald J.; Barantsevitch, Eugene N., Compounds and compositions for delivering active agents.
  62. Sarubbi, Donald J.; Barantsevitch, Evgueni, Compounds and compositions for delivering active agents.
  63. Boutignon, Francois, Compressed microparticles for dry injection.
  64. Korsatko Werner (Graz ATX), Compressed products with retarded release of active substance, a process for their preparation and a process for the lon.
  65. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Khare, Taruna Arora; Adler, Beverly S.; Martin, Francis H., Conjugated toxin peptide therapeutic agents.
  66. Sabel Bernhard A. (Munich MA DEX) Freese Andrew (Jamaica Plain MA) Saltzman William M. (Somerville MA), Controlled drug delivery system for treatment of neural disorders.
  67. Shalati Mohamad D. (Richton Park IL) Sivaramakrishnan Kallidaikurichi N. (Terre Haute IN), Controlled release delivery system for macromolecules.
  68. Sirkar Kamalesh K. ; Farrell Stephanie ; Basu Rahul, Controlled release device and method based on aqueous--organic partitioning in porous membranes.
  69. Sirkar Kamalesh K. ; Farrell Stephanie ; Basu Rahul, Controlled release device based on aqueous-organic partitioning in porous membranes.
  70. Fujioka Keiji,JPX ; Hirasawa Takeshi,JPX ; Kajihara Masako,JPX ; Sano Akihiko,JPX ; Sugawara Shuichi,JPX ; Urabe Yosuke,JPX, Controlled release drug formulation of open end cylindrical rod form.
  71. Sano,Akihiko; Kajihara,Masako; Sugie,Toshihiko, Controlled release preparations having multi-layer structure.
  72. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V., DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression.
  73. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Arora Khare, Taruna; Adler, Beverly S.; Martin, Francis H., DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression.
  74. Horowitz Bruce S. (16300 N. Park Pl. Southfield MI 48075), Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member.
  75. Milstein Sam J. ; Barantsevitch Evgueni N., Desferrioxamine oral delivery system.
  76. Lamoureux, Gary A.; Matons, James; Johnston, Warren; Bouffard, Matthew; Rice, Warren, Devices to resist migration and rotation of implants used in brachytherapy and other radiation therapy.
  77. Milstein Sam J., Diketopiperazine-based delivery systems.
  78. Milstein Sam J. (Larchmont NY), Diketopiperazine-based delivery systems.
  79. Rapsey, Jane; Svehla, Martin; Schuller, Peter; Miller, Christopher Robert, Drug delivery using a sacrificial host.
  80. Stokes Kenneth B. (Minneapolis MN), Drug dispensing body implantable lead employing molecular sieves and methods of fabrication.
  81. Siegel, Steven; Winey, Karen, Drug-containing PLA implants and methods of use thereof.
  82. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  83. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  84. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  85. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  86. Dadd, Fysh; Rapsey, Jane; Gibson, Peter; Schuller, Peter; Newbold, Carrie, Drug-delivery accessory for an implantable medical device.
  87. Dadd, Fysh; Rapsey, Jane; Gibson, Peter; Schuller, Peter; Newbold, Carrie, Drug-delivery accessory for an implantable medical device.
  88. Biscup, Robert S., Electro-stimulation and medical delivery device.
  89. Biscup,Robert S., Electro-stimulation and medical delivery device.
  90. Cady,Susan Mancini; Macar,Claude; Gibson,John W., Extended release growth promoting two component composition.
  91. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  92. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  93. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  94. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  95. Kaplan, Edward J., Flexible and/or elastic brachytherapy seed or strand.
  96. Milstein Sam J., Fragrances and flavorants.
  97. Bertozzi, Carolyn R.; Song, Jie; Lee, Seung-Wuk, Hydroxyapatite-binding peptides for bone growth and inhibition.
  98. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  99. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  100. Huc Alain (2 rue Verdi Sainte-Foy-Les-Lyon FRX) Le Pivert Patrick (2 rue Verdi 06000 Nice FRX) Gimeno Ren (Pelussin FRX), Implantable, biocompatible reservoirs permitting conservation, cellular culturing, or controlled liberation of an active.
  101. Gibson, Peter, Implantatable component having an accessible lumen and a drug release capsule for introduction into same.
  102. Kelly L. Thomas (Rte. 1 ; Box 68 St. Ignatius MT 59865) Hamel Esther V. M. (Rte. 1 ; Box 68 St. Ignatius MT 59865) Bielka Robert P. (2211 N. 59th St. Seattle WA 98103), Implanted anchor and insert with analog display.
  103. Kelly L. Thomas (Rte. 1 ; Box 68 St. Ignatius MT 59865) Hamel Esther V. M. (Rte. 1 ; Box 68 St. Ignatius MT 59865) Bielka Robert P. (2211 N. 59th St. Seattle WA 98103), Implanted muscle powered drug dispensing system.
  104. Lamoureux, Gary A.; Matons, James; Johnston, Warren W.; Bouffard, Matthew; Rice, Warren, Implants including spacers for use in brachytherapy and other radiation therapy that resist migration and rotation.
  105. Gibson, Peter, Independently-manufactured drug delivery module and corresponding receptacle in an implantable medical device.
  106. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  107. Richards, William L.; Ashby, Austin; Ketterer, Matthew; Marshall, Kevin; Harrison, Josh; Mette, Matthew; Richards, Paul; Showalter, Wayne; Cote, Jasmin; Halbert, Phillip C.; Bourgeois, Solene; Metzger, Steven W.; Hance, Ken; Mensack, Meghan; Michel, Carlos; Allers, Elke; Gamage, Dulini; Prisbrey, Landon; Gusyatin, Oleg; Shamsheyeva, Alena; Turng, Ben; Ghusson, Andrew; Reinhardt, Kurt, Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing.
  108. Richards, William L.; Ashby, Austin; Ketterer, Matthew; Marshall, Kevin; Harrison, Josh; Mette, Matthew; Richards, Paul; Showalter, Wayne; Cote, Jasmin; Halbert, Phillip C.; Bourgeois, Solene; Metzger, Steven W.; Hance, Ken; Mensack, Meghan; Michel, Carlos; Allers, Elke; Gamage, Dulini; Prisbrey, Landon; Gusyatin, Oleg; Shamsheyeva, Alena; Turng, Ben; Ghusson, Andrew; Reinhardt, Kurt, Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing.
  109. DeSimone, Joseph M.; Williams, Michael S., Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same.
  110. Howard Matthew A. ; Mayberg Marc ; Grady M. Sean ; Ritter Rogers C. ; Gillies George T., Magnetic stereotactic system for treatment delivery.
  111. Howard Matthew A. ; Mayburg Mar ; Grady M. Sean ; Ritter Rogers C. ; Gillies George T., Magnetic stereotactic system for treatment delivery.
  112. Nova Michael P. ; Parandoosh Zahra ; Senyei Andrew E. ; Xiao Xiao-Yi ; David Gary S. ; Satoda Yozo ; Zhao Chanfeng ; Potash Hanan, Matrices with memories and uses thereof.
  113. Debruyne, Kristine; Fiedler, Dirk; Kaiser, Thomas; Kloeck, Ben; Milojevic, Dusan; Parker, John, Medical implant drug delivery device.
  114. Prisbrey, Landon; Blackmore, Elise; Hance, Kenneth R.; Metzger, Steven W.; Marshall, Kevin, Membrane-assisted purification.
  115. Greelis John Patrick ; Sirivong Mikxay ; Matsuura David G. ; Scott W. Tate ; Zupkas Paul F., Method and apparatus for placement and activation of a medical device within a body cavity.
  116. Richter, Jacob, Method and apparatus for treating bodily tissues with medicinal substance.
  117. Vilhardt Hans (Espergarde DKX), Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract.
  118. Lennox Charles D., Method and device for delivery of therapeutic agents in conjunction with isotope seed placement.
  119. Matsuura David G. ; Gillespie Walter Dean ; Greelis John Patrick ; Parsons Charles Lowell ; Sirivong Mikxay ; Zupkas Paul F., Method for delivering a medication.
  120. Ho Koc-Kan ; Leone-Bay Andrea, Method for preparing .omega.-aminoalkanoic acid derivatives from cycloalkanones.
  121. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  122. Kaplan, Edward J., Method of administering a therapeutically active substance.
  123. Janoff Andrew S. (Yardley PA) Cullis Pieter R. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Fountain Michael W. (Griggstown NJ) Ginsberg Richard S. (Monroe NJ) Hope Michael J. (Vancouver CAX) Madd, Method of dehydrating liposomes using protective sugars.
  124. Hawiger Jack J. (Chestnut Hill MA) Timmons Sheila (Boston MA) Lukas Thomas J. (Nashville TN) Kloczewiak Marek (Boston MA), Method of inhibiting and inducing human platelet aggregation.
  125. Hawiger Jack J. (Chestnut Hill MA) Timmons Sheila (Boston MA) Kloczewiak Marek (Boston MA), Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vess.
  126. Siegel, Steven; Winey, Karen, Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant.
  127. Gschneidner David ; O'Toole Doris ; Freeman John, Method of preparing salicyloylamino acids.
  128. Hawiger Jack J. (Chestnut Hill MA) Timmons Sheila (Boston MA) Kloczewiak Marek (Jamaica Plain MA), Method of producing biologically active molecules having extended life time.
  129. Martin L. Kantor, Method of solubilizing and encapsulating itraconazole.
  130. Kantor Martin L., Method of solubilizing itraconazole.
  131. Hosobuchi Yoshio (116 Kinross Dr. San Rafael CA 94901) Lee Nancy M. (1830 Funston Ave. San Francisco CA 94116) Loh Horace H. (54 Mendosa San Francisco CA 94116) Chang Jaw-Kang (90 Curtis Ct. San Carl, Method of treating cerebral ischemia.
  132. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
  133. Haggard,Jeff; Wilkie,Arnold; Brang,James; Taylor,Jerry, Methods of forming ultra-fine fibers and non-woven webs.
  134. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., Methods of using OSK1 peptide analogs.
  135. Martin L. Kantor ; Evgueni Barantsevitch ; Sam J. Milstein, Microencapsulated fragrances and method for preparation.
  136. Milstein Sam J., Microspheres of diamide-dicarboxylic acids.
  137. Shekalim, Avraham, Miniature implanted drug delivery devices and inserter systems for introducing such devices.
  138. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  139. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  140. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  141. Leone-Bay Andrea ; Ho Koc-Kan ; Press Jeffery Bruce ; Wang Nai-Fang, Modified amino acids and compositions comprising the same for delivering active agents.
  142. Leone-Bay Andrea (Ridgefield CT) Wang Nai F. (Long Island City NY), Modified amino acids for drug delivery.
  143. Leone-Bay Andrea ; Wang Nai Fang, Modified amino acids for drug delivery.
  144. Milstein Sam J. ; Barantsevitch Evgueni N., Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof.
  145. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., OSK1 peptide analogs and pharmaceutical compositions.
  146. Milstein Sam J. ; Barantsevitch Evgueni ; Leone-Bay Andrea ; Wang Nai Fang ; Sarubbi Donald J. ; Santiago Noemi B, Oral delivery composition comprising supramolecular complex.
  147. Sarubbi Donald J. ; Leone-Bay Andrea ; Paton Duncan R., Oral drug delivery compositions and methods.
  148. Castan, Catherine; Guimberteau, Florence; Meyrueix, Rémi, Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s).
  149. Castan, Catherine; Guimberteau, Florence; Meyrueix, Rémi, Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s).
  150. Steiner Solomon S. (Mt. Kisco NY), Orally administerable ANF.
  151. Sam J. Milstein ; Evgueni Barantsevitch ; Andrea Leone-Bay ; Nai Fang Wang ; Donald J. Sarubbi ; Noemi B Santiago, Orally deliverable supramolecular complex.
  152. Huille Sylvain,FRX ; Lemercier Alain,FRX ; Soula Gerard,FRX, Particles based on polyamino acid(s) and capable of being used as delivery vehicles for active principle(s) and method.
  153. Huille, Sylvain; Nicolas, Florence; Brison, Nathan; Soula, Gerard, Particles based on polyamino-acid(s) and methods for preparing same.
  154. Bobee Jean-Marc (Verrires le Buisson FRX) Melin Christian (Verrires le Buisson FRX), Pharmaceutical tablet for the treatment of uraemia.
  155. Angot, Stéphanie; Breyne, Olivier; Chan, You-Ping; Soula, Gérard, Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof.
  156. Chan, You-Ping; Angot, Stéphanie; Breyne, Olivier, Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications.
  157. Soula, Olivier; Soula, Rémi; Breyne, Olivier, Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes.
  158. Chan, You-Ping; Bonnet-Gonnet, Cecile; Breyne, Olivier, Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof.
  159. Katsarava, Ramaz; Alavidze, Zemphira, Polymer blends as biodegradable matrices for preparing biocomposites.
  160. Katsarava,Ramaz; Alavidze,Zemphira, Polymer blends as biodegradable matrices for preparing biocomposites.
  161. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA) Warshawsky Abraham (Rehovot MA ILX) Edelman Elazar (Brookline MA), Polymer composite for controlled release or membrane formation.
  162. Siegel, Steven J.; Winey, Karen I.; Gur, Raquel E.; Lenox, Robert H., Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use.
  163. Sabel Bernhard A. (Egmating DEX) Freese Andrew (Jamaica Plain MA) Saltzman William M. (Baltimore MD) During Matthew J. (Westport CT), Polymeric device for controlled drug delivery to the CNS.
  164. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  165. Reed, Jay; Helle, Kevin; Rapach, Mike; Shanks, Charles E., Products and methods for brachytherapy.
  166. Milstein Sam J. (Larchmont NY) Kantor Martin L. (Mamaroneck NY), Proteinoid carriers and methods for preparation and use thereof.
  167. Sam J. Milstein ; Martin L. Kantor, Proteinoid carriers and methods for preparation and use thereof.
  168. Kantor Martin L., Proteinoid emulsions and methods for preparation and use thereof.
  169. Milstein Sam J. (Brooklyn NY) Kantor Martin L. (Mamaroneck NY), Proteinoid microspheres and methods for preparation and use thereof.
  170. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  171. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  172. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  173. Shamsheyeva, Alena; Howson, David C.; Metzger, Steven W., Rapid determination of microbial growth and antimicrobial susceptibility.
  174. Metzger, Steven W.; Howson, David C.; Goldberg, David A.; Buttry, Daniel A., Rapid microbial detection and antimicrobial susceptibility testing.
  175. Michael P. Nova ; Andrew E. Senyei, Remotely programmable matrices with memories.
  176. Nova Michael P. ; Senyei Andrew E., Remotely programmable matrices with memories.
  177. Nova Michael P. ; Senyei Andrew E. ; David Gary S., Remotely programmable matrices with memories.
  178. Siegel, Steven; Winey, Karen, Risperidone-containing PLA:PGA implants and methods of use thereof.
  179. Siegel, Steven; Winey, Karen, Risperidone-containing implants and methods of use thereof.
  180. Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
  181. Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
  182. Shekalim, Avraham, Slow release liquid drug delivery device.
  183. Hoey Michael (Shoreview MN) Gehlbach Peter (Minneapolis MN), Smooth muscle chemical pacemaker.
  184. Kantor Martin L. (Mamaroneck NY), Spray drying method and apparatus.
  185. Silvestri Loui J. (Miramar FL) Pyle H. Ruth (Ft. Lauderdale FL), Sustained release dosage form.
  186. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  187. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  188. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  189. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  190. Michael John Rathbone NZ; Craig Robert Bunt NZ; Shane Burggraaf NZ, Synchronizing of animal oestrus and intra vaginal devices useful therein.
  191. Soula, Rémi; Chan, You-Ping; Soula, Gérard; Breyne, Olivier, Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications.
  192. Moreau Jacques-Pierre (Upton MA) Kitchell Judith P. (Newton MA), Therapeutic agent delivery system.
  193. Lamoureux, Gary A.; Matons, James; Johnston, Warren; Bouffard, Matthew; Rice, Warren, Therapeutic member including a rail used in brachytherapy and other radiation therapy.
  194. Bonutti, Peter M., Therapeutic system.
  195. Nabel,Elizabeth G.; Nabel,Gary J., Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor.
  196. Gibson, John W.; Tipton, Arthur J.; Holl, Richard J.; Meador, Stacey, Zero-order prolonged release coaxial implants.
  197. Gibson, John W.; Tipton, Arthur J.; Holl, Richard; Meador, Stacey, Zero-order prolonged release coaxial implants.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로